BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12360557)

  • 41. Postencephalitic stereotyped involuntary movements responsive to L-Dopa.
    Picard F; de Saint-Martin A; Salmon E; Hirsch E; Marescaux C
    Mov Disord; 1996 Sep; 11(5):567-70. PubMed ID: 8866499
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SCA2 and SCA3 mutations in young-onset dopa-responsive parkinsonism.
    Svetel M; Djarmati A; Dragasević N; Savić D; Culjković B; Romac S; Kostić VS
    Eur J Neurol; 2003 Sep; 10(5):597. PubMed ID: 12940846
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Familial parkinsonism with the abnormalities in putamen on MRI].
    Kuru S; Kato T; Sakai M; Konagaya M; Sobue G; Matsuoka Y
    Rinsho Shinkeigaku; 2000 Jul; 40(7):741-5. PubMed ID: 11186916
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical and genetic evaluation of 8 Polish families with levodopa-responsive parkinsonism.
    Krygowska-Wajs A; Kachergus JM; Hulihan MM; Farrer MJ; Searcy JA; Booij J; Berendse HW; Wolters ECh; Wszolek ZK
    J Neural Transm (Vienna); 2005 Nov; 112(11):1487-502. PubMed ID: 15785861
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is levodopa toxic to human substantia nigra?
    Rajput AH; Fenton Me; Birdi S; Macaulay R
    Mov Disord; 1997 Sep; 12(5):634-8. PubMed ID: 9380042
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A patient with proximal myotonic myopathy and parkinsonism.
    Chu K; Cho JW; Song EC; Jeon BS
    Can J Neurol Sci; 2002 May; 29(2):188-90. PubMed ID: 12035844
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [L-dopa-resistant Parkinson's disease with cerebral atrophy: striato-nigral degeneration?].
    Dell'Aria V; Ciannella L; Melone MA
    Acta Neurol Quad (Napoli); 1981; 42():212-5. PubMed ID: 7270052
    [No Abstract]   [Full Text] [Related]  

  • 48. A case of late onset striatonigral degeneration.
    Przedborski S; Schiffmann SN; Monseu G; Maloteaux JM; Flament-Durand J
    Acta Neurol Belg; 1989; 89(1):29-37. PubMed ID: 2508411
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Greek-American kindred with autosomal dominant, levodopa-responsive parkinsonism and anticipation.
    Markopoulou K; Wszolek ZK; Pfeiffer RF
    Ann Neurol; 1995 Sep; 38(3):373-8. PubMed ID: 7668822
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pontine atrophy in spinocerebellar ataxia type 6.
    Sugawara M; Toyoshima I; Wada C; Kato K; Ishikawa K; Hirota K; Ishiguro H; Kagaya H; Hirata Y; Imota T; Ogasawara M; Masamune O
    Eur Neurol; 2000; 43(1):17-22. PubMed ID: 10601803
    [TBL] [Abstract][Full Text] [Related]  

  • 51. (99m)Tc-TRODAT-1 and (123)I-IBZM SPECT studies in a patient with extrapontine myelinolysis with parkinsonian features.
    Wu YC; Peng GS; Cheng CA; Lin CC; Huang WS; Hsueh CJ; Lee JT
    Ann Nucl Med; 2009 Jun; 23(4):409-12. PubMed ID: 19381760
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anticholinergic drugs: response of parkinsonism not responsive to levodopa.
    Yamada H; Momose T; Okada M; Kuroiwa Y
    J Neurol Neurosurg Psychiatry; 2002 Jan; 72(1):111-3. PubMed ID: 11784836
    [TBL] [Abstract][Full Text] [Related]  

  • 53. White matter hyperintense lesions in genetically proven spinocerebellar ataxia 8.
    Kumar N; Miller GM
    Clin Neurol Neurosurg; 2008 Jan; 110(1):65-8. PubMed ID: 17920187
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical features and neuroimaging of PARK7-linked parkinsonism.
    Dekker M; Bonifati V; van Swieten J; Leenders N; Galjaard RJ; Snijders P; Horstink M; Heutink P; Oostra B; van Duijn C
    Mov Disord; 2003 Jul; 18(7):751-7. PubMed ID: 12815653
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of nigrostriatal dysfunction in spinocerebellar ataxia 17.
    Salvatore E; Varrone A; Sansone V; Nolano M; Bruni AC; De Rosa A; Santoro L; Pappatà S; Filla A; De Michele G
    Mov Disord; 2006 Jun; 21(6):872-5. PubMed ID: 16532453
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Positron emission tomography and magnetic resonance imaging in spinocerebellar ataxia type 2: a study of symptomatic and asymptomatic individuals.
    Inagaki A; Iida A; Matsubara M; Inagaki H
    Eur J Neurol; 2005 Sep; 12(9):725-8. PubMed ID: 16128876
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [L-dopa-resistant parkinsonism with cerebral atrophy: striato-nigral degeneration? 2 cases].
    Dell'Aria V; Ciannella L; Melone MA
    Acta Neurol (Napoli); 1981 Feb; 3(1):212-5. PubMed ID: 7246294
    [No Abstract]   [Full Text] [Related]  

  • 58. Spinocerebellar ataxia type 1 mimicking stiff person syndrome.
    Singhal S; Gontu V; Choudhary P; Auer D; Bajaj N
    Mov Disord; 2009 Oct; 24(14):2158-60. PubMed ID: 19705462
    [No Abstract]   [Full Text] [Related]  

  • 59. Levodopa responsive Parkinsonism in adults with Angelman Syndrome.
    Harbord M
    J Clin Neurosci; 2001 Sep; 8(5):421-2. PubMed ID: 11535008
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Parkinsonism in SCA19/22: Dopamine Transporter Imaging in an Italian Family Harboring a Novel Mutation.
    Contaldi E; Gallo S; Corrado L; D'Alfonso S; Magistrelli L
    Cerebellum; 2024 Jun; 23(3):1226-1230. PubMed ID: 37857779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.